Home » Topics » Regulatory » Patents

Patents
RSS

Green Cross reveals potent, selective angiotensin II antagonists

April 6, 1998

Novel antimicrobial compounds for Clostridium infections described by Abbott

April 3, 1998

New prenyl transferase inhibitors in development at BMS

April 3, 1998

Pfizer discovers compounds useful as cytokine and cell adhesion molecule inhibitors

April 3, 1998

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Neurogen prepares new class of brain GABA receptor ligands

April 3, 1998

New inhibitors of cell adhesion in development at Kao

April 3, 1998

Banyu develops factor Xa inhibitors as antiplatelet/antithrombotic agents

April 2, 1998

Mochida prepares novel agents for disorders associated with eosinophilia

April 2, 1998

Broad-spectrum antibacterial agents synthesized by Daiichi

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...